Literature DB >> 1416554

Lower endogenous androgen levels and dyslipidemia in men with non-insulin-dependent diabetes mellitus.

E Barrett-Connor1.   

Abstract

OBJECTIVE: To compare plasma androgen levels in diabetic and nondiabetic men and to determine their relation to diabetic dyslipidemia.
DESIGN: A population-based, case-control study.
SETTING: Community. PARTICIPANTS: Men 53 to 88 years of age from the Rancho Bernardo, California, cohort who were screened for diabetes using an oral glucose tolerance test. MEASUREMENTS: Plasma androgen levels were compared in 44 men with untreated non-insulin-dependent diabetes mellitus and 88 age-matched men who had a normal glucose tolerance test. The relation of lipid and lipoprotein levels to androgen level and diabetic status was assessed before and after adjusting for covariates.
RESULTS: Men with diabetes had significantly lower plasma levels of free (4.96 nmol/L compared with 5.58 nmol/L) and total testosterone (14.7 nmol/L compared with 17.4 nmol/L), dihydrotestosterone (428 pg/mL compared with 533 pg/mL), and dehydroepiandrosterone sulfate (DHEA-S) (1.92 mumol/L compared with 2.42 mumol/L) than nondiabetic men. They also had significantly lower high-density lipoprotein (HDL) cholesterol and significantly higher triglyceride levels. Differences were not explained by obesity, alcohol use, or cigarette habit. Overall, the total testosterone level, but not the free testosterone level, was positively correlated with the HDL cholesterol level (P = 0.009) and negatively correlated with the triglyceride level (P = 0.0001). Similar associations were seen in analyses restricted to the men without diabetes.
CONCLUSIONS: Lower levels of endogenous androgens are seen in older diabetic men, and low androgen levels are associated with diabetic dyslipidemia.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1416554     DOI: 10.7326/0003-4819-117-10-807

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  50 in total

Review 1.  Dihydrotestosterone: Biochemistry, Physiology, and Clinical Implications of Elevated Blood Levels.

Authors:  Ronald S Swerdloff; Robert E Dudley; Stephanie T Page; Christina Wang; Wael A Salameh
Journal:  Endocr Rev       Date:  2017-06-01       Impact factor: 19.871

Review 2.  Aging and sex hormones in males.

Authors:  Maria Chiara Decaroli; Vincenzo Rochira
Journal:  Virulence       Date:  2016-11-10       Impact factor: 5.882

3.  Androgen receptor transcriptionally regulates μ-opioid receptor expression in rat trigeminal ganglia.

Authors:  Ki Seok Lee; Youping Zhang; Jamila Asgar; Q-Schick Auh; Man-Kyo Chung; Jin Y Ro
Journal:  Neuroscience       Date:  2016-06-16       Impact factor: 3.590

Review 4.  Risks versus benefits of testosterone therapy in elderly men.

Authors:  S Basaria; A S Dobs
Journal:  Drugs Aging       Date:  1999-08       Impact factor: 3.923

Review 5.  Management of prostate cancer in HIV-positive patients.

Authors:  Matthew S Wosnitzer; Franklin C Lowe
Journal:  Nat Rev Urol       Date:  2010-04-27       Impact factor: 14.432

6.  Testosterone and the metabolic syndrome.

Authors:  Vakkat Muraleedharan; T Hugh Jones
Journal:  Ther Adv Endocrinol Metab       Date:  2010-10       Impact factor: 3.565

7.  Diabetes mellitus and risk of prostate cancer in the health professionals follow-up study.

Authors:  Jocelyn S Kasper; Yan Liu; Edward Giovannucci
Journal:  Int J Cancer       Date:  2009-03-15       Impact factor: 7.396

Review 8.  Androgen deficiency and aging in men.

Authors:  R S Swerdloff; C Wang
Journal:  West J Med       Date:  1993-11

9.  The association between dehydroepiandosterone and frailty in older men and women.

Authors:  M Voznesensky; S Walsh; D Dauser; J Brindisi; A M Kenny
Journal:  Age Ageing       Date:  2009-03-09       Impact factor: 10.668

Review 10.  The many faces of testosterone.

Authors:  Jerald Bain
Journal:  Clin Interv Aging       Date:  2007       Impact factor: 4.458

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.